MithunVShahMDPhD

PubMed

• IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation.
  Lih En Hong, Mihir D Wechalekar, Monika Kutyna, Annabelle Small, Kelly Lim, Chloe Thompson-Peach, Joule J Li, Rakchha Chhetri, Hamish S Scott, Anna Brown, Christopher ...> ;Blood. 2024 May 2
• Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.
  Isla M Johnson, Omer Karrar, Masooma Rana, Moazah Iftikhar, Sunny Chen, Kristen McCullough, Antoine N Saliba, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Mark Litzow...> ;British Journal of Haematology. 2024 Apr 1
• Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent.
  Nickolas Steinauer, Kristen McCullough, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Torghabeh, Mark R Litzow, Wi...> ;Haematologica. 2024 Mar 28
• Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.
  Gordon J Ruan, Saurabh Zanwar, Aishwarya Ravindran, Susan Schram, Jithma P Abeykoon, Antonious Hazim, Jason R Young, Mithun V Shah, N Nora Bennani, Liuyan Jiang, Diana...> ;American Journal of Hematology. 2024 May 1
• Features and Factors Associated With Myeloid Neoplasms After Chimeric Antigen Receptor T-Cell Therapy.
  Mark Gurney, Anmol Baranwal, Allison Rosenthal, Mohamed A Kharfan-Dabaja, Saad S Kenderian, Yi Lin, Mithun Vinod Shah> ;JAMA Oncology. 2024 Apr 1
• Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms.
  Anmol Baranwal, Rong He, Hemant S Murthy, Mehrdad Hefazi, Aref Al-Kali, Hassan B Alkhateeb, Rami Basmaci, David Viswanatha, Patricia Greipp, James Foran, Jeanne Palmer...> ;Blood Advances. 2024 Feb 13
• 12 citations
  Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive...
  Naseema Gangat, Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla M Johnson, Maymona Abdelmagid, Mostafa Abdallah, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begn...> ;American Journal of Hematology. 2024 Feb 1
• Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms.
  Anmol Baranwal, Mark Gurney, Rami Basmaci, Bahga Katamesh, Rong He, David S Viswanatha, Patricia Greipp, James Foran, Talha Badar, Hemant Murthy, Cecilia Arana Yi, Jea...> ;Haematologica. 2024 Feb 1
• EASIX and CPSS Cytogenetics score-based composite risk model for patients with CMML undergoing allogeneic transplant.
  Anmol Baranwal, Abhishek Mangaonkar, Mithun V Shah, Aref Al-Kali, Ayalew Tefferi, William J Hogan, Mark R Litzow, Mrinal M Patnaik, Hassan B Alkhateeb> ;Bone Marrow Transplantation. 2024 Apr 1
• Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients.
  Heybati, K., Ochal, D., Al-Khateeb, H., Sklar, D., Herasevich, S., Torghabeh, M., Hogan, W., Litzow, M., Shah, M., Durani, U., Bauer, P., Gajic, O., Yadav, H.> ;Annals of Hematology. 2024 Mar 1
• Spectrum of therapy-related clonal cytopenias and neoplasms after exposure to Lutetium-177-Dotatate.
  Kendi, A., Pritzl, S., Kusne, Y., Halfdanarson, T., Hobday, T., Sonbol, M., Mangaonkar, A., Gangat, N., Shah, M., Patnaik, M.> ;Leukemia Research. 2024 Jan 1
• 2 citations
  Long-term outcomes among adults with Langerhans cell histiocytosis.
  Gaurav Goyal, Aldo A Acosta-Medina, Jithma P Abeykoon, Chen Dai, Aishwarya Ravindran, Robert Vassallo, Jay H Ryu, Mithun V Shah, N Nora Bennani, Jason R Young, Corrie ...> ;Blood Advances. 2023 Nov 14
• 3 citations
  BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis.
  Aldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag, Jithma P Abeykoon, Jelske Forma-Borst, Eline C Steenwijk, Elizabeth A M Feijen, Jop C Teepen, N Nora Bennani, Susa...> ;Blood. 2023 Nov 2
• The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma under...
  Saurabh Zanwar, Eapen K Jacob, Carl Greiner, Kevin Pavelko, Michael Strausbauch, Emilie Anderson, Arini Arsana, Megan Weivoda, Mithun Vinod Shah, Taxiarchis Kourelis> ;Blood Cancer Journal. 2023 Sep 26
• 2 citations
  A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy.
  Ariel Kleman, Arun Singavi, Lauren Pommert, Angela J Mathison, Parameswaran Hari, Binod Dhakal, Meera Mohan, Siegfried Janz, Jennifer M Knight, Mithun V Shah, Carolina...> ;Blood Advances. 2023 Sep 26
• U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.
  Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithu...> ;Blood Cancer Journal. 2023 Sep 21
• Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy.
  Zhuoer Xie, Terra Lasho, Arushi Khurana, Alejandro Ferrer, Christy Finke, Abhishek A Mangaonkar, Stephen Ansell, Jenna Fernandez, Mithun Vinod Shah, Aref Al-Kali, Nase...> ;Haematologica. 2024 Feb 1
• Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia.
  Naseema Gangat, Kristen McCullough, Maymona Abdelmagid, Omer Karrar, Marissa Powell, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek Mangaonkar, Antoine Saliba,...> ;Haematologica. 2024 Jan 1
• 1 citations
  Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML).
  Mark Gurney, Abhishek A Mangaonkar, Terra Lasho, Christy Finke, Aref Al-Kali, Naseema Gangat, Mithun V Shah, Hassan B Alkhateeb, Ayalew Tefferi, David Sallman, Zhuoer ...> ;Leukemia. 2023 Aug 1
• Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival.
  Naseema Gangat, Andrew Kuykendall, Najla Al Ali, Swati Goel, Maymona Abdelmagid, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek Mangaonkar, Mark R Litzow, ...> ;Blood Advances. 2023 Jun 27
• 11 citations
  Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis.
  Brittany Knick Ragon, Mithun Vinod Shah, Anita D'Souza, Noel Estrada-Merly, Lohith Gowda, Gemlyn George, Marcos de Lima, Shahrukh Hashmi, Mohamed A Kharfan-Dabaja, Nav...> ;Blood Advances. 2023 Jun 27
• Reply.
  Samantha A Banks, M Tariq Bhatti, Ronald S Go, Jithma P Abeykoon, Aldo A Acosta-Medina, Antonious Z Hazim, Gaurav Goyal, Jason R Young, Matthew J Koster, Robert Vassal...> ;Ophthalmology. 2023 Sep 1
• Neurological Manifestations of Histiocytic Disorders.
  Samantha A Banks, Julio C Sartori Valinotti, Ronald S Go, Jithma P Abeykoon, Gaurav Goyal, Matthew J Koster, Robert Vassallo, Jay H Ryu, Caroline J Davidge-Pitts, Aish...> ;Current Neurology and Neuroscience Reports. 2023 Jun 1
• 3 citations
  Clinical and molecular correlates of somatic and germlinevariants in patients and families with myeloid neoplasms.
  Talha Badar, Ahmad Nanaa, James M Foran, David Viswanatha, Aref Al-Kali, Terra Lasho, Christy Finke, Hassan B Alkhateeb, Rong He, Naseema Gangat, Mithun Shah, Ayalew T...> ;Haematologica. 2023 Nov 1
• 2 citations
  Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience.
  Bahga Katamesh, Ahmad Nanaa, Rong He, David Viswanatha, Phuong Nguyen, Patricia Greipp, Kurt Bessonen, Naseema Gangat, Kebede Begna, Abhishek Mangaonkar, Mrinal Patnai...> ;Blood Advances. 2023 Apr 25
• Join now to see all

Journal Articles

• Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction Drugs  
  Krina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature

Abstracts/Posters

• Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis
  Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Characteristics and Outcomes of Therapy Related Myeloid Neoplasms in Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation
  Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial
  Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Survival Outcomes Following Allogeneic Stem Cell Transplantation for Inherited Bone Marrow Failure and Myeloid Germline Predisposition Syndromes
  Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis
  Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Molecular Alterations in Adult Histiocytic Neoplasms
  Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Flurabine Improves Transplant Outcomes in Older MDS Patients
  Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma
  Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018